MedDataX Logo

Coronary CT Angio Evaluating Graft Patency in ACS Patients Treated With DAPT or Single ASA After CABG (CoCAP)

NCT ID: NCT04783701

Last Updated: 2025-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

360 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-05-17

Study Completion Date

2026-03-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the presence of graft patency in single aspirin vs dual anti platelet therapy (DAPT) treatment including ticagrelor in patients with acute coronary syndrome (ACS) treated with coronary artery bypass surgery (CABG). Follow up time is 12-36 months postoperatively and the patency will be evaluated with coronary computed tomography angiography (CCTA)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndrome Coronary Bypass Stenosis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Acute coronary syndrome Coronary bypass surgery Coronary computed tomography angiography Antiplatelet therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Previously included in TACSI-trial

Exclusion Criteria

* Highly irregular heart rhythm (i.e. atrial fibrillation)
* Chronic kidney disease with estimated glomerular filtration rate (eGFR) \<45ml/min/1,73m2
* Body weight \>120 kg
* Previous severe allergic reaction (i.e. anaphylactic reaction) to iodine-based contrast agents
* Not able to communicate
* Not willing to participate
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Linkoeping

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jonas Holm

MD, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Heart Disease, Haukeland University Hospital

Bergen, , Norway

Site Status ENROLLING_BY_INVITATION

St Olavs University Hospital

Trondheim, , Norway

Site Status NOT_YET_RECRUITING

Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine

Gothenburg, , Sweden

Site Status ENROLLING_BY_INVITATION

Dep of Vascular and Thoracic Surgery

Örebro, , Sweden

Site Status ACTIVE_NOT_RECRUITING

Department of Cardiothoracic Surgery Karolinska University Hospital

Stockholm, , Sweden

Site Status ENROLLING_BY_INVITATION

University Hospital Linköping

Linköping, Östergötland County, Sweden

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Norway Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jonas Holm, MD, PhD

Role: CONTACT

Phone: +46101034498

Email: [email protected]

Sofia Sederholm Lawesson, MD, PhD

Role: CONTACT

Phone: +461037472

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alexander Wahba, MD, Prof

Role: primary

Jonas Holm, MD,PhD

Role: primary

Sofia Sederholm Lawesson, MD,PhD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CoCAP

Identifier Type: -

Identifier Source: org_study_id